Page last updated: 2024-11-02

phenobarbital and Chagas Disease

phenobarbital has been researched along with Chagas Disease in 1 studies

Phenobarbital: A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
phenobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups.

Chagas Disease: Infection with the protozoan parasite TRYPANOSOMA CRUZI, a form of TRYPANOSOMIASIS endemic in Central and South America. It is named after the Brazilian physician Carlos Chagas, who discovered the parasite. Infection by the parasite (positive serologic result only) is distinguished from the clinical manifestations that develop years later, such as destruction of PARASYMPATHETIC GANGLIA; CHAGAS CARDIOMYOPATHY; and dysfunction of the ESOPHAGUS or COLON.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Plumas-Marty, B1
Verwaerde, C1
Loyens, M1
Velge, P1
Taibi, A1
Cesbron, MF1
Capron, A1
Ouaissi, MA1

Other Studies

1 other study available for phenobarbital and Chagas Disease

ArticleYear
Trypanosoma cruzi glutathione-binding proteins: immunogenicity during human and experimental Chagas' disease.
    Parasitology, 1992, Volume: 104 Pt 1

    Topics: Animals; Antigens, Protozoan; Chagas Disease; Chromatography, Affinity; Enzyme-Linked Immunosorbent

1992